Company / Current Assets per Share
Stoke Therapeutics, Inc. Current Assets per Share History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets per Share
$5.66
FY2025
5-year range
$5.07 / $6.61
FY2021-FY2025
Trend
+11.6%
vs FY2024
Sector context
#127 of 210
Health Care
What the data says
At $5.66, Stoke Therapeutics, Inc.'s current assets per share ranks #127 of 210 in the Health Care sector. Current Assets per Share returned to growth in FY2025 after 2 years of decline, reaching $5.66.
Based on SEC 10-K filings.
5.66 in FY2025 with a 5-year CAGR of -8.4%.
Improved from $5.46 to $5.66 over the past 2 years.
Health Care sector context is included.
Current Assets per Share over time
Growth rates
- 3-Year CAGR
- -5.1%
- 5-Year CAGR
- -8.4%
- 10-Year CAGR
- -
Sector benchmark
#127 of 210 in Health CareTop 60% of 210This company $5.66 Sector average $170.65
▼
-96.7% below sector average
Key checks
Key Insights
- In FY2025, current assets per share increased 11.6% year-over-year.
- Ranks #127 out of 210 companies in the Health Care sector.
- Peak current assets per share was recorded in FY2018.
- Lowest current assets per share in the period was in FY2024.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Assets per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $5.66 | +11.6% |
| FY2024 | $5.07 | -7.2% |
| FY2023 | $5.46 | -17.4% |
| FY2022 | $6.61 | +6.0% |
| FY2021 | $6.24 | -28.9% |
| FY2020 | $8.78 | -30.2% |
| FY2019 | $12.58 | -91.6% |
| FY2018 | $149.64 | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026